
What data tells us about births and deaths in India, in 5 charts
On 7 May, the government released the much-awaited Sample Registration System data, after a gap of three years as opposed to the usual two-year gap, which offered a glimpse into the key trends in births, deaths, fertility, and gender ratio, among others.
An earlier Mint explainer explored 'excess deaths' in India in 2021, a year which saw a devastating second wave of covid. Beyond the excess deaths, the report also shows a decline in life expectancy in the latest period and a rise in respiratory infections as a cause of death, both of which may be linked to covid. At the same time, the report also reveals improvements in several indicators related to births.
Mint explores these aspects in five charts:
Life expectancy: shorter
For the first time in five decades, life expectancy declined in India on a five-year moving average basis in 2017-21. According to the latest report, total life expectancy declined to 69.8 years in 2017-21 from 70.0 years in 2016-2020.
The decline can be explained by the excess deaths, nearly 2.1 million more than what was expected based on past trends, in 2021. Notably, the decline was seen among the male population, with their life expectancy reduced to 68.2 years in 2017-21 from 68.6 years in 2016-2020.
Also read: In charts: Why a good pulses output is an urgent need this year
On the other hand, life expectancy among females, which is already higher than males, continued to rise to 71.6 years from 71.4 years. While India has seen a healthy rise in increase in life expectancy—barring the recent decline—over the years, the country is still behind its key emerging market peers like China (78 years), Malaysia (77 years), Brazil (76 years) and Thailand (76 years), as per World Bank data.
Causes of death: many
The covid pandemic may have caused a rare increase in deaths due to respiratory infections in 2019-21, but heart diseases remained the biggest cause of deaths in the country.
Deaths due to respiratory infections surged to 9.2% of the total deaths in 2019-21 compared to 3.6% in 2017-19 (a pre-pandemic period). At the same time, deaths due to heart diseases not only remained the biggest cause but also witnessed an increase during the period, with their share rising to 30.2% in 2019-21 from 28.9% in 2017-19.
While non-communicable diseases such as heart disease, cancer, and diabetes led to a majority of deaths (54.9%) in 2019-21, communicable diseases such as respiratory infections and fever of unknown origin witnessed an increased share of deaths in 2019-21 at 23.9%, compared to 21.5% in 2017-19.
Among the top ten causes of death, diabetes ranked seventh in 2019-21, even though it was not among the top 10 causes in 2017-19, signalling an increased danger from the disease.
Gender ratio: mixed gains
India's sex ratio at birth—the number of females per 1,000 males—rose to 913 in 2019-21 from 898 in 2014-16, marking a steady but encouraging trend in achieving gender balance in the demographics. Among the states, Kerala had the highest sex ratio of 962, while Uttarakhand (852) and Delhi (863) were at the bottom.
A further analysis showed that some states with historically low ratios, like Rajasthan, Gujarat and Haryana, saw a sizeable improvement in 2019-21 compared to 2014-16. From 857 females per 1,000 males in the five-year-ago period, Rajasthan witnessed the ratio rise to 920—putting it above the national average and lifting its rank to 11 from 18 earlier.
At the same time, some states, particularly Odisha, witnessed a decline in the gender ratio, giving mixed signals on the progress made so far. Among the 22 states and union territories with a population of 10 million or more for which data were given, six had a gender ratio below 900.
Also read: In charts: Young Indians are patriotic and progressive, but politically disengaged
Child gap: desirable
Most Indians are choosing to have a gap of three years or more between two live births, signalling better family planning and greater awareness over the health of the mother.
The data showed that 52.4% of Indians had a birth interval of three or more years between two children in 2021, an increase from 51.9% five years ago. In 2011, only 42% of Indians had three or more years of gap between two live births.
This improvement has come against the backdrop of schemes such as the Prerna Scheme, which involves incentivising couples from below poverty line (BPL) groups for maintaining a three-year birth gap between their first and second child.
However, a sizeable proportion of Indians (nearly 25%) continued to see less than two years of gap between two children. Among the states, Madhya Pradesh had the lowest percentage (35.3%) of people with three or more years of birth spacing, followed by Bihar (44.8%).
Childbirths: more formalized
Institutional births, which involve giving birth at a medical facility under the supervision of trained healthcare professionals, have gone up over the years.
Data showed that over 90% of births were institutional births in 2021, up from about 80% a decade ago. This was led by a sharp increase in births at government hospitals, whose share increased to 66% in 2021 from 45% in 2011.
Government hospitals were more prominent in rural areas, with 68% of births as opposed to about 60% in urban areas. Among the states, government hospitals were more prevalent in Jammu and Kashmir, while private hospitals were more prevalent in Kerala.
As better care and more professional help became available to women during pregnancy, the maternal mortality ratio came down to 93 per 100,000 live births in 2019-20 from 130 in 2014-16. Similarly, the infant mortality rate declined to 27 per 1,000 live births in 2021 from 39 in 2014.
Also read: How covid transformed tech and where challenges persist, in five charts

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Mint
2 days ago
- Mint
How Medikabazaar's new CEO is trying to turn around the business, target profitability this year
Medikabazaar, the medical equipment supplier, expects to put the controversies surrounding the startup behind it as it targets profitability this year, CEO Dinesh Lodha told Mint in an exclusive interview. The startup, which is entangled in legal disputes, has started exports and is expanding its portfolio offerings to drive growth. Lodha, who was appointed group CEO in August 2024, said the business is turning around and that will help rebuild confidence among its investors and customers. 'This is the third quarter going on, [since] I joined, and in the last two quarters there are significant changes happening in the business. We have cut down our loss by 80% by quarter four from quarter one," he told Mint. 'In Q4 we ended up at a revenue run rate of ₹2,200 crore, with some losses. Next year, we're looking at a run rate of ₹3,200 crore by Q4FY26, with Ebitda profitability. For the first time the company will show a solid profitability and a good cash flow." Lodha said his mandate is to run the business and that the dispute between investors is not a distraction. 'The team is very focused. And my approach is also very focused," said Lodha. 'The way things are getting turned around, I think people are getting more and more confident. We are not losing customers because of this." The Mumbai-based B2B medical supply chain platform has been mired in controversy and legal disputes following a whistleblower complaint in December 2023 accusing the then-senior management of round-tripping of accounts to inflate revenue and other irregularities. The allegations have been validated by forensic audits. The company's auditor resigned, its FY23 financials were restated, and its leadership was overhauled. Founder's ouster Co-founder Vivek Tiwari stepped down as chief executive officer in July 2024 to take on a board role. He was then ousted by the company's board in April 2025 over allegations of malicious and fraudulent activities, including financial mismanagement and financial fraud. Tiwari is fighting cases in multiple jurisdictions, including the Delhi High Court and the National Company Law Tribunal. In an earlier interview to Mint, he denied allegations of financial misreporting. Also Read | Medikabazaar's ousted CEO denies board's allegations of financial irregularities Additionally, the company's Series C investors including Creagis, CDC Group, HealthQuad and Ackermans & van Haaren, filed an indemnity claim, or compensation, of ₹279 crore against the company over allegations of financial misreporting. Lodha comes with over two decades of experience in the healthcare and medtech space, having previously worked as group CEO at Healthium Medtech, country head for Samsung's healthcare vertical, and sales director at GE Healthcare. He has 'a proven track record of leading successful turnarounds of businesses," according to his LinkedIn profile. Medikabazaar reported a gross operating revenue of ₹1,355.5 crore in FY24, a 50% surge from the preceding year, according to Entrackr. Its loss widened by 30% to ₹394.8 crore. The company's expansion is driven by adding new growth segments and an internal clean-up with a focus on transparency. 'If you ask me one word in this organisation which I've tried to change, it is to 'empower' the people to take decisions, but then be accountable," he said. The company has had a good retention of its leadership, employees and customers over the past 18 months, Lodha said. 'That itself gives you confidence that things are pretty much solid in place," Lodha said. 'We have added many new segments, new leaders. But we retain the core," he added. Exports to drive growth Lodha is driving the company's expansion beyond Indian shores. The company is already facilitating Indian manufacturers with certification to export to countries in the Middle East, Africa, some parts of Asia, and South America. 'It is in the early stages… but it is a huge, significant growth area for us as we go forward. At this point of time, export [segment] is not that significant. We are talking 5-6% of our business. But that will significantly grow to 15-20% as we go forward," Lodha said. Also Read | The fallout of an audit and missed targets: Medikabazaar founders set to lose stock options Medikabazaar is a B2B seller for medical equipment and drugs, including consumables such as surgical gloves, devices like MRI machines, and vaccines. It has over 400,000 customers through its digital marketplace and has tied up with over 1,000 hospitals in the country. The company has also started its own brand called MB+ for medical consumables, pharmaceuticals, and vaccines that it will directly offer to customers, which is a high-margin business and will form a significant chunk of the company's revenue, said Lodha. It is targeting tier-2 and tier-3 hospitals and aims to offer complete supply chain and procurement solutions to at least 100-150 hospitals in the next 12-14 months. 'In India, nobody has the portfolio breadth that we have with presence in equipment and devices, consumables, disposables, IVD (in vitro diagnostics) and pharma," said Lodha. 'We offer a one-stop solution in all procurement segments… that's a very big opportunity for hospitals to really work with one company as a single-window procurement partner rather than working with, say, 200 distributors." Medikabazaar competes with large manufacturers in individual segments such as medical equipment companies Wipro GE Healthcare and Medtronic, as well as other B2B marketplaces MedDeal and Zoplar. Also Read | Indian medtech's just coming of age, and already has global ambitions Medikabazaar has raised $165 million (about ₹1,380 crore) via debt and equity to date. It was reportedly in talks to raise $150-200 million last year, which did not materialise after the forensic audit. Lodha said that the company is not looking at raising funds currently and that it built a good cash flow in Q4. 'We are continuing to be focused on cash flow," he said. 'Wherever the investment is required, I think the existing investors [are] very bullish on the business… they are ready to fund it further."


Mint
3 days ago
- Mint
COVID-19 update, 4 June 2025: 7 new deaths in India over last 24 hours, active toll jumps over 4,300 — latest updates
COVID-19 news, 4 June updates: The Ministry of Health and Family Welfare (MoH&FW) data shows that seven people have lost their lives, and the nation's active COVID-19 cases now stand at 4,302 as of 5 June 2025. The daily updating database also highlighted that 276 new COVID-19 cases have been added to the official numbers as of Wednesday. The Ministry data sheds light on 44 people losing their lives to the global pandemic, which made a recent comeback in India. 1. Delhi: The national capital reported the death of one, 22-year-old female who lost her life due to lower respiratory tract infection, COVID pneumonia, shock and Type 1 respiratory failure. 2. Maharashtra: The State reported four deaths in the last 24 hours, with the first one a 55-year-old man with Cardiac Arrythmia and was on antiarrythimics. The second person was a 73-year-old male with Cardiogenic Shock, Parkinson's Disease, COVID-19 pneumonia, and Hypertension. The third person who lost their life was a 23-year-old female with Diabetes Mellitus and HTN. The fourth death was of a 27-year-old male with IHD with old PTB, LRTI, and alcohol withdrawal seizure. 3. Tamil Nadu: The State reported one death in the last 24 hours, a 76-year-old male with Acute Respiratory Distress Syndrome (ARDS), COVID-19 pneumonia, and sepsis with multi-organ dysfunction syndrome (MODS). 4. Gujarat: The State reported one death without any details so far. According to the Ministry of Health and Family Welfare data, so far, 3,281 people have been cured/discharged/migrated since 1 January 2025, and in the last 24 hours, 581 people have been added to the list. The Indian government has asked the States and the Union territories to increase their individual healthcare preparedness to ensure that there is availability of oxygen, ventilators, and essential medicines at hospitals amid COVID-19 comeback concerns, according to an earlier Mint report. 'In view of the recent increase in covid-19 cases in India, a series of technical review meetings were held on 2nd and 3rd June under chairpersonship of Dr Sunita Sharma, director general of health services (DGHS), with representatives of Disaster Management Cell, Emergency Management Response (EMR) Cell, National Centre for Disease Control (NCDC), Indian Council of Medical Research (ICMR), Integrated Disease Surveillance Programme (IDSP) and central government hospitals in Delhi along with representatives from all states and UTs to evaluate the current Covid-19 situation and preparedness measures,' Mint reported citing officials aware of the development. The officials also mentioned that the deaths being reported, the people already had pre-existing illnesses of some sort. The government also has plans to conduct more mock drills to check the nation's preparedness for health facilities, according to the report.

The Hindu
3 days ago
- The Hindu
Door-to-door survey to compile data of persons with disabilities begins in Salem district
Work has begun to compile data of all persons with disabilities in Salem district to ensure doorstep delivery of welfare benefits, said Collector R. Brindha Devi here on Wednesday. Addressing the media after inspecting the door-to-door survey at Kannankurichi, she said the State government was implementing the TN Rights Project, funded by the World Bank, through which benefits of welfare schemes are delivered directly to the homes of persons with disabilities. She added that the government has initiated steps across all districts to visit every household, identify all categories of persons with disabilities, and create a comprehensive social data platform with their complete details. This data collection drive began on June 2, 2025, and is currently under way, with field staff visiting homes in both urban and rural areas. The Collector said that when field staff visit homes, persons with disabilities may present documents such as their national identity card, Aadhaar card, bank passbook, and ration card for verification. In households without persons with disabilities, only the Aadhaar card and ration card can be shown. To ensure that no person with a disability is left out, a dedicated mobile application has been developed for this purpose, enabling accurate and complete data collection from every household. This initiative will ensure that all future assistance reaches persons with disabilities directly at their place of residence without delay. For further information, the public may contact the District Welfare Office for Persons with Disabilities at 0427-2415242. R. Magizhnan, District Differently Abled Welfare Officer, and other concerned officials were present during the inspection.